Table 3: Summary of available epidemiologic data by outcome and country.

Total NHL DLBCL and FL Adult ALL Pediatric ALL MM CLL North and South America I P S I P S I P S I P S I P S I P S United States ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ Canada ✓ ✓ ✓       ✓   ✓ ✓ *   ✓ * ✓ ✓ ✓ ✓   ✓ Brazil ✓ †     ✓ †     ✓ *†     ✓ *†     ✓ †     ✓ *†     European Union-5 I P S I P S I P S I P S I P S I P S United Kingdom ✓ ✓ ✓ ✓     ✓     ✓   ✓ ✓ ✓ ✓ ✓   ✓ England ✓ ✓ ✓ ✓ †     ✓           ✓ ✓ ✓ ✓     Ireland ✓     ✓                 ✓   ✓       Republic of Ireland ✓   ✓ ✓   ✓ ✓   ✓ ✓     ✓   ✓ ✓   ✓ Northern Ireland ✓ ✓ ✓ ✓     ✓   ✓       ✓ ✓ ✓ ✓   ✓ Scotland ✓ ✓ ✓       ✓ ✓         ✓ ✓ ✓ ✓ ✓   Wales ✓ ✓ ✓       ✓ ✓ ✓ ✓ *     ✓ ✓ ✓ ✓ ✓ ✓ France ✓ ✓ ✓ †             ✓ *   ✓ ✓ ✓ ✓ ✓     Germany ✓ ✓ ✓ ✓ †     ✓ †     ✓ *   ✓ * ✓   ✓ ✓ †     Italy ✓ ✓ ✓       ✓ ✓ ✓ * ✓   ✓ ✓ ✓ ✓ ✓ ✓ ✓ * Spain ✓   ✓ †       ✓ *†     ✓ *   ✓ ✓     ✓ *†     Asia I P S I P S I P S I P S I P S I P S China ✓   ✓ †       ✓ *   ✓ *† ✓ *†     ✓   ✓ † ✓ *   ✓ *† Japan ✓           ✓           ✓           South Korea ✓ ✓ ✓       ✓ * ✓ * ✓ *† ✓ * ✓ *   ✓ ✓ ✓ ✓ * ✓ * ✓ *† India ✓ †   ✓ †       ✓ *†     ✓ *†   ✓ *† ✓ †     ✓ *†     Australia I P S I P S I P S I P S I P S I P S Australia ✓   ✓ ✓     ✓     ✓ *   ✓ ✓     ✓

ALL: acute lymphoblastic leukemia; CLL: chronic lymphocytic leukemia; DLBCL: diffuse large B-cell lymphoma; FL: follicular lymphoma; I: incidence; MM: multiple myeloma; NHL: non-Hodgkin’s lymphoma; P: prevalence; S: survival. *Data on lymphoid leukemia were used as a proxy for ALL and CLL. †Regional estimates were used a proxy for national estimates.